Kornelius Wiechmann
Overview
Explore the profile of Kornelius Wiechmann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
243
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hupfeld J, Gorr I, Schwald C, Beaucamp N, Wiechmann K, Kuentzer K, et al.
Biotechnol Bioeng
. 2014 Jun;
111(11):2290-302.
PMID: 24890974
Mesenchymal stromal cells (MSCs) are promising candidates for cell therapy. Their therapeutic use requires extensive expansion to obtain a sufficiently high number of cells for clinical applications. State-of-the-art expansion systems,...
2.
Wegmeyer H, Broske A, Leddin M, Kuentzer K, Nisslbeck A, Hupfeld J, et al.
Stem Cells Dev
. 2013 May;
22(19):2606-18.
PMID: 23676112
Mesenchymal stromal cells (MSCs) are rare progenitor cells that can be isolated from various tissues. They exhibit multilineage differentiation potential, support regenerative processes, and interact with various immune cells. Therefore,...
3.
Niederfellner G, Lammens A, Mundigl O, Georges G, Schaefer W, Schwaiger M, et al.
Blood
. 2011 Mar;
118(2):358-67.
PMID: 21444918
CD20 is a cell-surface marker of normal and malignant B cells. Rituximab, a monoclonal antibody targeting CD20, has improved the treatment of malignant lymphomas. Therapeutic CD20 antibodies are classified as...